Skip Nav Destination
Delayed donor red cell chimerism and pure red cell aplasia following major ABO-incompatible nonmyeloablative hematopoietic stem cell transplantation
The significance of bcr-abl molecular detection in chronic myeloid leukemia patients “late,” 18 months or more after transplantation
Phase 1 study of polyethylene glycol formulation of interferon α-2B (Schering 54031) in Philadelphia chromosome–positive chronic myelogenous leukemia
Relationships between age at diagnosis, clinical features, and outcome of therapy in children treated in the Medical Research Council AML 10 and 12 trials for acute myeloid leukemia
High remission rate in T-cell prolymphocytic leukemia with CAMPATH-1H
Deletions of the derivative chromosome 9 occur at the time of the Philadelphia translocation and provide a powerful and independent prognostic indicator in chronic myeloid leukemia
No difference in graft-versus-host disease, relapse, and survival comparing peripheral stem cells to bone marrow using unrelated donors
Early immunophenotypical evaluation of minimal residual disease in acute myeloid leukemia identifies different patient risk groups and may contribute to postinduction treatment stratification
The presence of a FLT3 internal tandem duplication in patients with acute myeloid leukemia (AML) adds important prognostic information to cytogenetic risk group and response to the first cycle of chemotherapy: analysis of 854 patients from the United Kingdom Medical Research Council AML 10 and 12 trials
Antiphospholipid antibodies and antiphospholipid syndrome in patients presenting with immune thrombocytopenic purpura: a prospective cohort study
Specific von Willebrand factor–cleaving protease in thrombotic microangiopathies: a study of 111 cases
Differential cellular targets of Epstein-Barr virus (EBV) infection between acute EBV-associated hemophagocytic lymphohistiocytosis and chronic active EBV infection
Expression of high Km 5′-nucleotidase in leukemic blasts is an independent prognostic factor in adults with acute myeloid leukemia
Issue Archive
September 15 2001
Table of Contents
INSIDE BLOOD
PLENARY PAPERS
ERRATA
REVIEW ARTICLES
CHEMOKINES
CLINICAL OBSERVATIONS, INTERVENTIONS, AND THERAPEUTIC TRIALS
Delayed donor red cell chimerism and pure red cell aplasia following major ABO-incompatible nonmyeloablative hematopoietic stem cell transplantation
Clinical Trials & Observations
Charles D. Bolan,Susan F. Leitman,Linda M. Griffith,Robert A. Wesley,Jo L. Procter,David F. Stroncek,A. John Barrett,Richard W. Childs
The significance of bcr-abl molecular detection in chronic myeloid leukemia patients “late,” 18 months or more after transplantation
Clinical Trials & Observations
Jerald P. Radich,Ted Gooley,Eileen Bryant,Tom Chauncey,Reginald Clift,Lan Beppu,Scott Edmands,Mary E. D. Flowers,Keith Kerkof,Ross Nelson,Frederick R. Appelbaum
Phase 1 study of polyethylene glycol formulation of interferon α-2B (Schering 54031) in Philadelphia chromosome–positive chronic myelogenous leukemia
Clinical Trials & Observations
Moshe Talpaz,Susan O'Brien,Esther Rose,Samir Gupta,Jianqin Shan,Jorge Cortes,Francis J. Giles,Stefan Faderl,Hagop M. Kantarjian
Relationships between age at diagnosis, clinical features, and outcome of therapy in children treated in the Medical Research Council AML 10 and 12 trials for acute myeloid leukemia
Clinical Trials & Observations
David K. H. Webb,Georgina Harrison,Richard F. Stevens,Brenda G. Gibson,Ian M. Hann,Keith Wheatley,for the MRC Childhood Leukaemia Working Party
High remission rate in T-cell prolymphocytic leukemia with CAMPATH-1H
Clinical Trials & Observations
Claire E. Dearden,Estella Matutes,Bruno Cazin,Geir E. Tjønnfjord,Antonio Parreira,Benet Nomdedeu,Pietro Leoni,Fiona J. Clark,Deepti Radia,Saad M. B. Rassam,Tony Roques,Nicolas Ketterer,Vasantha Brito-Babapulle,Martin J. S. Dyer,Daniel Catovsky
Deletions of the derivative chromosome 9 occur at the time of the Philadelphia translocation and provide a powerful and independent prognostic indicator in chronic myeloid leukemia
Clinical Trials & Observations
Brian J. P. Huntly,Alistair G. Reid,Anthony J. Bench,Lynda J. Campbell,Nick Telford,Patricia Shepherd,Jeff Szer,H. Miles Prince,Paul Turner,Colin Grace,Elizabeth P. Nacheva,Anthony R. Green
No difference in graft-versus-host disease, relapse, and survival comparing peripheral stem cells to bone marrow using unrelated donors
Clinical Trials & Observations
Mats Remberger,Oolle Ringdén,Igor-Wolfgang Blau,Hellmut Ottinger,Bernhard Kremens,Micheil G. Kiehl,Johan Aschan,Dietrich W. Beelen,Nadezda Basara,Gunilla Kumlien,Axel A. Fauser,Volker Runde
Early immunophenotypical evaluation of minimal residual disease in acute myeloid leukemia identifies different patient risk groups and may contribute to postinduction treatment stratification
Clinical Trials & Observations
Jesús F. San Miguel,Marı́a B. Vidriales,Consuelo López-Berges,Joaquı́n Dı́az-Mediavilla,Norma Gutiérrez,Consuelo Cañizo,Fernando Ramos,Marı́a J. Calmuntia,José J. Pérez,Marcos González,Alberto Orfao
The presence of a FLT3 internal tandem duplication in patients with acute myeloid leukemia (AML) adds important prognostic information to cytogenetic risk group and response to the first cycle of chemotherapy: analysis of 854 patients from the United Kingdom Medical Research Council AML 10 and 12 trials
Clinical Trials & Observations
Panagiotis D. Kottaridis,Rosemary E. Gale,Marion E. Frew,Georgina Harrison,Stephen E. Langabeer,Andrea A. Belton,Helen Walker,Keith Wheatley,David T. Bowen,Alan K. Burnett,Anthony H. Goldstone,David C. Linch
Antiphospholipid antibodies and antiphospholipid syndrome in patients presenting with immune thrombocytopenic purpura: a prospective cohort study
Clinical Trials & Observations
Reyhan Diz-Küçükkaya,Abdullah Hacıhanefioǧlu,Mustafa Yenerel,Mehmet Turgut,Hüseyin Keskin,Meliha Nalçacı,Murat l˙nanç
Specific von Willebrand factor–cleaving protease in thrombotic microangiopathies: a study of 111 cases
Clinical Trials & Observations
HEMATOPOIESIS
HEMOSTASIS, THROMBOSIS, AND VASCULAR BIOLOGY
IMMUNOBIOLOGY
Differential cellular targets of Epstein-Barr virus (EBV) infection between acute EBV-associated hemophagocytic lymphohistiocytosis and chronic active EBV infection
Clinical Trials & Observations
Yoshihito Kasahara,Akihiro Yachie,Kenkichi Takei,Chiharu Kanegane,Kanae Okada,Kazuhide Ohta,Hidetoshi Seki,Noboru Igarashi,Keiko Maruhashi,Keita Katayama,Eiji Katoh,Gaku Terao,Yukio Sakiyama,Shoichi Koizumi
NEOPLASIA
Expression of high Km 5′-nucleotidase in leukemic blasts is an independent prognostic factor in adults with acute myeloid leukemia
Clinical Trials & Observations
Carlos M. Galmarini,Kathryn Graham,Xavier Thomas,Fabien Calvo,Philippe Rousselot,Assia El Jafaari,Emeline Cros,John R. Mackey,Charles Dumontet
Enhanced ceramide generation and induction of apoptosis in human leukemia cells exposed to DT388–granulocyte-macrophage colony-stimulating factor (GM-CSF), a truncated diphtheria toxin fused to human GM-CSF
Alex Senchenkov,Tie-Yan Han,Hongtao Wang,Arthur E. Frankel,Timothy J. Kottke,Scott H. Kaufmann,Myles C. Cabot
PHAGOCYTES
RED CELLS
TRANSPLANTATION
BRIEF REPORTS
CORRESPONDENCE
Myelodysplastic syndromes standardized response criteria: further definition
Bruce D. Cheson,John M. Bennett,Hagop Kantarjian,Charles A. Schiffer,Stephen D. Nimer,Bob Löwenberg,Richard M. Stone,Moshe Mittelman,Guillermo F. Sanz,Pierre W. Wijermans,Peter L. Greenberg,for the International Working Group to Standardize Response Criteria for the Myelodysplastic Syndromes
A novel, possibly functional, single nucleotide polymorphism in the coding region of the thrombin-activatable fibrinolysis inhibitor (TAFI) gene is also associated with TAFI levels
Geert-Jan Brouwers,Hans L. Vos,Frank W. G. Leebeek,Saskia Bulk,Mark Schneider,Michael Boffa,Marlys Koschinsky,Nico H. van Tilburg,Michael E. Nesheim,Rogier M. Bertina,Encarnación B. Gómez Garcı́a
-
Cover Image
Cover Image
Advertisement intended for health care professionals
Email alerts
Advertisement intended for health care professionals